These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 28599244
21. Anti-diabetic effects of shubat in type 2 diabetic rats induced by combination of high-glucose-fat diet and low-dose streptozotocin. Manaer T, Yu L, Zhang Y, Xiao XJ, Nabi XH. J Ethnopharmacol; 2015 Jul 01; 169():269-74. PubMed ID: 25922265 [Abstract] [Full Text] [Related]
22. Glucagon-Like Peptide-1 Mediates the Protective Effect of the Dipeptidyl Peptidase IV Inhibitor on Renal Fibrosis via Reducing the Phenotypic Conversion of Renal Microvascular Cells in Monocrotaline-Treated Rats. Xu J, Wang J, Cheng Y, Li X, He M, Zhu J, Han H, Wei G, Kong H, Xie W, Wang H, Zuo X. Biomed Res Int; 2018 Jul 01; 2018():1864107. PubMed ID: 29607314 [Abstract] [Full Text] [Related]
23. Glucagon-like peptide-1 attenuates liver injury in the rat diabetes model. Yang Z, Guo C, Ma J, Lu Y, Xuan L, Huang Y, Yang X, Zhao M, Luo Y. Pak J Pharm Sci; 2019 Jan 01; 32(1(Supplementary)):309-313. PubMed ID: 30829208 [Abstract] [Full Text] [Related]
24. GLP-1 Receptor Blockade Reduces Stimulated Insulin Secretion in Fasted Subjects With Low Circulating GLP-1. Gray SM, Hoselton AL, Krishna R, Slentz CA, D'Alessio DA. J Clin Endocrinol Metab; 2022 Aug 18; 107(9):2500-2510. PubMed ID: 35775723 [Abstract] [Full Text] [Related]
25. Sitagliptin inhibits EndMT in vitro and improves cardiac function of diabetic rats through the SDF-1α/PKA pathway. Wu Y, Xu M, Bao H, Zhang JH. Eur Rev Med Pharmacol Sci; 2019 Jan 18; 23(2):841-848. PubMed ID: 30720193 [Abstract] [Full Text] [Related]
26. Nutrient induced type 2 and chemical induced type 1 experimental diabetes differently modulate gastric GLP-1 receptor expression. Bloch O, Broide E, Ben-Yehudah G, Cantrell D, Shirin H, Rapoport MJ. J Diabetes Res; 2015 Jan 18; 2015():561353. PubMed ID: 25893200 [Abstract] [Full Text] [Related]
27. Sitagliptin prevents inflammation and apoptotic cell death in the kidney of type 2 diabetic animals. Marques C, Mega C, Gonçalves A, Rodrigues-Santos P, Teixeira-Lemos E, Teixeira F, Fontes-Ribeiro C, Reis F, Fernandes R. Mediators Inflamm; 2014 Jan 18; 2014():538737. PubMed ID: 24817793 [Abstract] [Full Text] [Related]
28. Abelmoschus esculentus subfractions improved nephropathy with regulating dipeptidyl peptidase-4 and type 1 glucagon-like peptide receptor in type 2 diabetic rats. Peng CH, Lin HC, Lin CL, Wang CJ, Huang CN. J Food Drug Anal; 2019 Jan 18; 27(1):135-144. PubMed ID: 30648566 [Abstract] [Full Text] [Related]
30. Sitagliptin and shock wave-supported peripheral blood derived endothelial progenitor cell therapy effectively preserves residual renal function in chronic kidney disease in rat-role of dipeptidyl peptidase 4 inhibition. Sung PH, Chen KH, Li YC, Chiang JY, Lee MS, Yip HK. Biomed Pharmacother; 2019 Mar 05; 111():1088-1102. PubMed ID: 30841422 [Abstract] [Full Text] [Related]
31. Sitagliptin attenuated brain damage and cognitive impairment in mice with chronic cerebral hypo-perfusion through suppressing oxidative stress and inflammatory reaction. Tsai TH, Sun CK, Su CH, Sung PH, Chua S, Zhen YY, Leu S, Chang HW, Yang JL, Yip HK. J Hypertens; 2015 May 05; 33(5):1001-13. PubMed ID: 25689400 [Abstract] [Full Text] [Related]
32. Exenatide and Sitagliptin Decrease Interleukin 1β, Matrix Metalloproteinase 9, and Nitric Oxide Synthase 2 Gene Expression But Does Not Reduce Alveolar Bone Loss in Rats With Periodontitis. Moraes RM, Lima GM, Oliveira FE, Brito AC, Pereira RC, Oliveira LD, Barros PP, Franco GC, Anbinder AL. J Periodontol; 2015 Nov 05; 86(11):1287-95. PubMed ID: 26205746 [Abstract] [Full Text] [Related]
33. Effects of selenium and exendin-4 on glucagon-like peptide-1 receptor, IRS-1, and Raf-1 in the liver of diabetic rats. Barakat GM, Moustafa ME, Bikhazi AB. Biochem Genet; 2012 Dec 05; 50(11-12):922-35. PubMed ID: 22983684 [Abstract] [Full Text] [Related]
34. Twelve week liraglutide or sitagliptin does not affect hepatic fat in type 2 diabetes: a randomised placebo-controlled trial. Smits MM, Tonneijck L, Muskiet MH, Kramer MH, Pouwels PJ, Pieters-van den Bos IC, Hoekstra T, Diamant M, van Raalte DH, Cahen DL. Diabetologia; 2016 Dec 05; 59(12):2588-2593. PubMed ID: 27627981 [Abstract] [Full Text] [Related]
35. Effect of concomitant administration of L-glutamine and cycloart-23-ene-3β, 25-diol (B2) with sitagliptin in GLP-1 (7-36) amide secretion, biochemical and oxidative stress in streptozotocin - nicotinamide induced diabetic Sprague Dawley rats. Badole SL, Chaudhari SM, Bagul PP, Mahamuni SP, Khose RD, Joshi AC, Raut CG, Zanwar AA. PLoS One; 2013 Dec 05; 8(8):e72817. PubMed ID: 24023648 [Abstract] [Full Text] [Related]
36. Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Phosphate Accelerates Cellular Cholesterol Efflux in THP-1 Cells. Komatsu T, Abe S, Nakashima S, Sasaki K, Higaki Y, Saku K, Miura SI, Uehara Y. Biomolecules; 2023 Jan 24; 13(2):. PubMed ID: 36830597 [Abstract] [Full Text] [Related]
37. Effects of glucagon-like peptide-1 on advanced glycation endproduct-induced aortic endothelial dysfunction in streptozotocin-induced diabetic rats: possible roles of Rho kinase- and AMP kinase-mediated nuclear factor κB signaling pathways. Tang ST, Zhang Q, Tang HQ, Wang CJ, Su H, Zhou Q, Wei W, Zhu HQ, Wang Y. Endocrine; 2016 Jul 24; 53(1):107-16. PubMed ID: 26758998 [Abstract] [Full Text] [Related]
38. Sitagliptin, a dipeptidyl peptidase-4 inhibitor, improves recognition memory, oxidative stress and hippocampal neurogenesis and upregulates key genes involved in cognitive decline. Gault VA, Lennox R, Flatt PR. Diabetes Obes Metab; 2015 Apr 24; 17(4):403-13. PubMed ID: 25580570 [Abstract] [Full Text] [Related]
39. Hepatic Fibroblast Growth Factor 21 Is Involved in Mediating Functions of Liraglutide in Mice With Dietary Challenge. Liu D, Pang J, Shao W, Gu J, Zeng Y, He HH, Ling W, Qian X, Jin T. Hepatology; 2021 Oct 24; 74(4):2154-2169. PubMed ID: 33851458 [Abstract] [Full Text] [Related]
40. Exenatide upregulates gene expression of glucagon-like peptide-1 receptor and nerve growth factor in streptozotocin/nicotinamide-induced diabetic mice. Gumuslu E, Cine N, Ertan M, Mutlu O, Komsuoglu Celikyurt I, Ulak G. Fundam Clin Pharmacol; 2018 Apr 24; 32(2):174-180. PubMed ID: 29091313 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]